QC
HZNP

Quent Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Quent Capital’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,125
Closed -$246K – 1366
2023
Q3 		$246K Buy
2,125
+110
+5% +$11.8K 0.04% 239
2023
Q2 		$207K Hold
2,015
– – 0.03% 280
2023
Q1 		$220K Buy
2,015
+19
+1% +$2.1K 0.04% 258
2022
Q4 		$227K Buy
1,996
+27
+1% +$2.24K 0.04% 243
2022
Q3 		$122K Buy
1,969
+160
+9% +$11.2K 0.03% 333
2022
Q2 		$144K Sell
1,809
-141
-7% -$13.4K 0.03% 285
2022
Q1 		$205K Buy
1,950
+434
+29% +$42.3K 0.04% 269
2021
Q4 		$163K Buy
+1,516
New +$165K 0.03% 315

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Quent Capital's HZNP Position: Q4 2023 in Review

Quent Capital sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 2,125 shares — an estimated $246K sold.

Quent Capital first reported a position in HZNP in Q4 2021 and held it in 8 quarters. The position peaked at $246K in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Quent Capital reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Quent Capital sold 2,125 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $246K.
  • Quent Capital first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021 and held it in 8 quarters.
  • Quent Capital's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $246K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Quent Capital's 13F filing for Q4 2023, filed 19 Jan 2024.